Inari Medical, Inc. Stock price

Equities

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
47.98 USD +1.22% Intraday chart for Inari Medical, Inc. +6.10% -26.09%
Sales 2024 * 588M Sales 2025 * 693M Capitalization 2.75B
Net income 2024 * -29M Net income 2025 * 13M EV / Sales 2024 * 4.08 x
Net cash position 2024 * 349M Net cash position 2025 * 344M EV / Sales 2025 * 3.47 x
P/E ratio 2024 *
-94.1 x
P/E ratio 2025 *
214 x
Employees 1,300
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.22%
1 week+4.87%
Current month+4.03%
1 month-17.66%
3 months-27.08%
6 months-27.49%
Current year-26.09%
More quotes
1 week
41.64
Extreme 41.635
49.05
1 month
39.90
Extreme 39.8987
51.00
Current year
39.90
Extreme 39.8987
66.35
1 year
39.90
Extreme 39.8987
71.85
3 years
39.90
Extreme 39.8987
116.41
5 years
39.55
Extreme 39.55
127.42
10 years
39.55
Extreme 39.55
127.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 17-08-31
Director of Finance/CFO 65 19-02-28
Chief Tech/Sci/R&D Officer - 19-03-31
Members of the board TitleAgeSince
Director/Board Member 64 11-08-31
Chairman 70 11-08-31
Director/Board Member 57 19-10-31
More insiders
Date Price Change Volume
24-03-28 47.98 +1.22% 10,287,240
24-03-27 47.4 +2.80% 2,151,764
24-03-26 46.11 +8.78% 2,616,779
24-03-25 42.39 -4.35% 1,138,000
24-03-22 44.32 -1.99% 914,199

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of thrombus from the peripheral vasculature. Its ProTrieve sheath is used for the removal of thrombus from the peripheral vasculature through aspiration. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. It also offers LimFlow System for Transcatheter Arterialization of the Deep Veins (TADV).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
47.98 USD
Average target price
73.7 USD
Spread / Average Target
+53.61%
Consensus
  1. Stock
  2. Equities
  3. Stock Inari Medical, Inc. - Nasdaq